Showing results (981-990 of 1,009) with videos related to
Sort By:
Pageof 101
ESC Heart Failure|July 15, 2022
Peak O2 -pulse predicts exercise training-induced changes in peak V̇O2 in heart failure with preserved ejection fractionStephan Mueller, Bernhard Haller, Anna Feuerstein, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Chronic myelogenous leukemia, version 1.2015Susan O'Brien, Jerald P Radich, Camille N Abboud, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 15, 2015
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasmsBrady L Stein, Jason Gotlib, Murat Arcasoy, et al.Science Translational Medicine|December 6, 2023
Intervertebral disc human nucleus pulposus cells associated with back pain trigger neurite outgrowth in vitro and pain behaviors in ratsWensen Jiang, Juliane D Glaeser, Giselle Kaneda, et al.Medical Image Analysis|June 26, 2026
Beyond the LUMIR challenge: The pathway to foundational registration modelsJunyu Chen, Shuwen Wei, Joel Honkamaa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)ValidationJulie Farand, Jeffrey E Kropf, Peter Blomgren, et al.Journal of the American Chemical Society|December 16, 2025
Unravelling the Stability Stressors of Atomically Dispersed Fe-N-C Oxygen Reduction CatalystsXiaohong Xie, Boyang Li, Pan Xu, et al.Nature|January 21, 2021
A stable low-temperature H2-production catalyst by crowding Pt on α-MoCXiao Zhang, Mengtao Zhang, Yuchen Deng, et al.Blood Advances|June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized studyPierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.Pageof 101